304 results on '"Sai, Ke"'
Search Results
2. TIM-3/CD68 double-high expression in Glioma: Prognostic characteristics and potential therapeutic approaches
3. Alterations in intratumoral and peripheral immune status in recurrent gliomas and their prognostic implications for patients underwent reoperation
4. Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription
5. Association between viral infections and glioma risk: a two-sample bidirectional Mendelian randomization analysis
6. Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center
7. Longitudinal impedance measurements and simulations of a three-metal-strip kicker
8. Incidence, trend and risk factors associated with suicide among patients with malignant intracranial tumors: a surveillance, epidemiology, and end results analysis
9. Driver mutations in ADGRL3 are involved in the evolution of ependymoma
10. Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell
11. Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening
12. CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1
13. Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors
14. Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells
15. Image-driven classification of functioning and nonfunctioning pituitary adenoma by deep convolutional neural networks
16. Management of Non–Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study
17. BIOM-36. PREOPERATIVE IMMUNE AND INFLAMMATORY FACTORS IN PERIPHERAL BLOOD PREDICT PROGNOSIS OF GLIOMA AND CORRELATE WITH GRADES AND SUBTYPES: A PROSPECTIVE MULTI-INSTITUTIONAL STUDY OF 1282 PATIENTS
18. EPID-09. ASSOCIATION BETWEEN VIRAL INFECTIONS AND GLIOMA RISK: A TWO-SAMPLE BI-DIRECTIONAL MENDELIAN RANDOMIZATION ANALYSIS
19. CTNI-77. POST-PROGRESSION TREATMENT AFTER VAL-083 WITH RADIATION IN NEWLY DIAGNOSED GBM MGMT UNMETHYLATED PATIENTS
20. Identify glioma recurrence and treatment effects with triple-tracer PET/CT
21. Preliminary study on detection and cleaning of parasitic bunches
22. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas
23. Options Trading and Stock Price Informativeness
24. TIPS-05 ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY FOLLOWING RADIOTHERAPY IN NEWLY DIAGNOSED LOW-GRADE GLIOMA PATIENT WITH RESIDUE TUMORS: A MULTICENTER, OPEN LABEL, RANDOMIZED TRIAL
25. Transforaminal Resection of Cervical Dumbbell Schwannomas in Patients with Additional Tumors
26. Skp2 modulates proliferation, senescence and tumorigenesis of glioma
27. Longitudinal impedance measurements and simulations of a three-metal-strip kicker
28. Fluorescein sodium-guided biopsy or resection in primary central nervous system lymphomas with contrast-enhancing lesion in MRI
29. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas
30. CGCG clinical practice guidelines for the management of adult diffuse gliomas
31. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China
32. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells
33. Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics
34. CTIM-13. LOCAL ADOPTIVE CELLULAR IMMUNOTHERAPY WITH CYTOKINE-INDUCED KILLER (CIK) CELLS FOR HIGH GRADE GLIOMAS: A PILOT STUDY WITH LONG-TERM FOLLOW-UP AND POTENTIAL FACTORS FOR SURVIVAL BENEFITS
35. SYST-04 PRELIMINARY REPORT OF A CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICIENCY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: A PROSPECTIVE, PHASE II, SINGLE-ARM STUDY
36. Unveiling the difference in the activity and selectivity of nickel based cocatalysts for CO2 photoreduction
37. Tail Risk around FOMC Announcements
38. β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1
39. Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060)
40. Histopathological features and prognosis of 91 paired reoperation of glioma patients: a cohort study from a single cancer center
41. Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study
42. Interstitial Chemotherapy for Malignant Gliomas
43. Preliminary study on detection and cleaning of parasitic bunches
44. Sinusitis Independently Predicts the Presence of Headache Following Endoscopic Transsphenoidal Resection for Pituitary Adenomas
45. Pleomorphic xanthoastrocytoma arising from the pituitary stalk
46. Lumber nerve root cavernous angioma
47. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
48. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1
49. Identify glioma recurrence and treatment effects with triple-tracer PET/CT
50. Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.